These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 188431)

  • 1. Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters: its significance for the mechanism of lipid lowering by clofibrate and related drugs.
    Beaumont JL; Dachet C
    Atherosclerosis; 1976; 25(2-3):255-66. PubMed ID: 188431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters.
    Beaumont JL; Dachet C
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):41-3. PubMed ID: 1019153
    [No Abstract]   [Full Text] [Related]  

  • 3. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B; Lithell H; Gustafsson IB; Borberg J
    Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of clofibrate, bile-sequestering agents and probucol on high-density lipoprotein levels.
    Glueck C
    Am J Cardiol; 1983 Aug; 52(4):28B-30B. PubMed ID: 6577781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum lipoproteins and antilipemic drugs related to clofibrate. Their in vitro interaction].
    Beaumont JL; Dachet C
    Atherosclerosis; 1973; 17(3):419-33. PubMed ID: 4351719
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
    Brattsand R
    Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
    [No Abstract]   [Full Text] [Related]  

  • 9. p-Chlorophenoxyisobutyrate enhanced retention of homologous lipoproteins by human aortic smooth muscle cells.
    Filipovic I; Buddecke E
    Lipids; 1977 Dec; 12(12):1069-77. PubMed ID: 201816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid class and molecular species interrelationships among plasma lipoproteins of normolipemic subjects.
    Kuksis A; Myher JJ; Geher K; Breckenridge WC; Jones GJ; Little JA
    J Chromatogr; 1981 Jun; 224(1):1-23. PubMed ID: 7263806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG; Hutt V; Klör HU; Ditschuneit H
    Artery; 1980; 8(6):519-29. PubMed ID: 7259531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
    Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.
    Bagdade JD; Shantharam VV; Sollek M; Albers JJ
    Clin Nephrol; 1979 Aug; 12(2):83-6. PubMed ID: 230927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of clofibrate in familial hypercholesterolemia.
    Pichardo R; Boulet L; Davignon J
    Atherosclerosis; 1977 Apr; 26(4):573-82. PubMed ID: 193524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clofibrate on lipid metabolism in streptozotocin diabetic rats.
    Cayen MN; Dubuc J; Dvornik D
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):752-7. PubMed ID: 165533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat.
    Carlson LA; Walldius G; Butcher RW
    Atherosclerosis; 1972; 16(3):349-57. PubMed ID: 4348601
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of nicotinic acid on the metabolism of the plasma lipoproteins of rhesus monkeys.
    Magide AA; Myant NB; Reichl D
    Atherosclerosis; 1975; 21(2):205-15. PubMed ID: 165824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.